Covered recipient · General Payments record
NATHAN M BULLINGTON
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$1,326.05
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $174.77 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $58.88 | 3 |
| AIMMUNE THERAPEUTICS, INC. | $46.77 | 2 |
| Paratek Pharmaceuticals, Inc. | $38.27 | 2 |
| Gilead Sciences, Inc. | $30.85 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $24.99 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146967045 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $21.78 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000845 | CMS |
| Gilead Sciences, Inc. | $14.10 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133818429 | CMS |
| Gilead Sciences, Inc. | $16.75 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133818431 | CMS |
| Merck Sharp & Dohme LLC | $16.35 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141721522 | CMS |
| Merck Sharp & Dohme LLC | $20.85 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141721666 | CMS |
| Merck Sharp & Dohme LLC | $21.68 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141721520 | CMS |
| Paratek Pharmaceuticals, Inc. | $18.62 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113894247 | CMS |
| Paratek Pharmaceuticals, Inc. | $19.65 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113894249 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.